U.S., Jan. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07313462) titled 'Escalation vs. Induction Therapy Strategy in Patients With Early-Onset MS After Age 50' on Dec. 17, 2025.
Brief Summary: The objective of this study is to evaluate the risk of inflammatory disease activity by retrospectively comparing two therapeutic strategies (escalation group and induction group). The investigators also aim to identify factors associated with inflammatory relapse and treatment-related complications.
Study Start Date: Feb. 07, 2025
Study Type: OBSERVATIONAL
Condition:
Multiple Sclerosis (MS)
Recruitment Status: RECRUITING
Sponsor: University Hospital, Strasbourg, France
Published by HT Digital Content Servic...